Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI

PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

July 31, 2013

Conditions
Myocardial InfarctionSTEMI
Interventions
DRUG

Prasugrel

treatment with a 60 mg loading dose prasugrel, followed by a maintenance dose of 10 mg for 30 days

DRUG

Clopidogrel

treatment with a 600 mg loading dose clopidogrel, followed by a maintenance dose of 75 mg for 30 days

Trial Locations (3)

12203

Charité Campus Benjamin Franklin, Med. Klinik II, Berlin

67063

Klinikum Ludwigshafen, Med. Klinik B, Ludwigshafen

75013

Hospital Pitie-Salpetriere, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Stiftung Institut fuer Herzinfarktforschung

OTHER